Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes

被引：6

作者：

Xiao, Qian ^{[1
,2
]}

Wang, Dan ^{[1
,2
]}

Li, Danyang ^{[2
]}

Huang, Jing ^{[1
,2
]}

Ma, Feifei ^{[1
,3
]}

Zhang, Haocheng ^{[1
,4
]}

Sheng, Yingda ^{[1
,2
]}

Zhang, Caimei ^{[1
,2
]}

Ha, Xiaoqin ^{[1
,2
]}

机构：

[1] Chinese Peoples Liberat Army Joint Secur Force, Dept Lab, Forty Hosp 9, 333 Nanbinhe Middle Rd, Lanzhou 730050, Gansu, Peoples R China

[2] Gansu Univ Tradit Chinese Med, Sch Publ Hlth, Lanzhou 730000, Gansu, Peoples R China

[3] Gansu Agr Univ, Coll Vet Med, Lanzhou 730070, Gansu, Peoples R China

[4] Lanzhou Univ, Sch Clin Med 2, Lanzhou 730030, Gansu, Peoples R China

来源：

JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2023年 / 37卷 / 09期

基金：

中国国家自然科学基金;

关键词：

Protein kinase C; Diabetes mellitus; Endothelial cell; Oxidative stress; Inflammation; AMYLOID PRECURSOR PROTEIN; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; DELTA-PKC; POTASSIUM CHANNELS; ACTIVATION; INHIBITION; GLUCOSE; PHOSPHORYLATION; MECHANISMS;

D O I：

10.1016/j.jdiacomp.2023.108565

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Protein kinase C (PKC) is a family of serine/threonine protein kinases that play an important role in many organs and systems and whose activation contributes significantly to endothelial dysfunction in diabetes. The increase in diacylglycerol (DAG) under high glucose conditions mediates PKC activation and synthesis, which stimulates oxidative stress and inflammation, resulting in impaired endothelial cell function. This article reviews the contribution of PKC to the development of diabetes-related endothelial dysfunction and summarizes the drugs that inhibit PKC activation, with the aim of exploring therapeutic modalities that may alleviate endothelial dysfunction in diabetic patients.

引用

页数：8

共 50 条

[1] Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Achari, Arunkumar E.
Jain, Sushil K.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (06)
[2] Protein kinase C as a therapeutic target
Teicher, Beverly A.
CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5336 - 5345
[3] Epsilon protein kinase C as a potential therapeutic target for the ischemic heart
Inagaki, Koichi
Churchill, Enic
Mochly-Rosen, Daria
CARDIOVASCULAR RESEARCH, 2006, 70 (02) : 222 - 230
[4] Protein kinase C, an elusive therapeutic target?
Mochly-Rosen, Daria
Das, Kanad
Grimes, Kevin V.
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (12) : 937 - 957
[5] Protein kinase C, an elusive therapeutic target?
Daria Mochly-Rosen
Kanad Das
Kevin V. Grimes
Nature Reviews Drug Discovery, 2012, 11 : 937 - 957
[6] Endothelial Dysfunction: From a Pathophysiological Mechanism to a Potential Therapeutic Target
Ambrosino, Pasquale
Grassi, Guido
Maniscalco, Mauro
BIOMEDICINES, 2022, 10 (01)
[7] Novel therapeutic approach to target endothelial dysfunction in type 2 diabetes
Sena, C. M.
Pereira, A. M.
Fernandes, R.
Santos-Silva, D.
Faustino, A.
Ceica, R.
CARDIOVASCULAR RESEARCH, 2014, 103
[8] Protein kinase Cα: disease regulator and therapeutic target
Konopatskaya, Olga
Poole, Alastair W.
TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (01) : 8 - 14
[9] Protein kinase C in heart failure: a therapeutic target?
Palaniyandi, Suresh Selvaraj
Sun, Lihan
Batista Ferreira, Julio Cesar
Mochly-Rosen, Daria
CARDIOVASCULAR RESEARCH, 2009, 82 (02) : 229 - 239
[10] Protein kinase Cα as a heart failure therapeutic target
Liu, Qinghang
Molkentin, Jeffery D.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (04) : 474 - 478

← 1 2 3 4 5 →